Visiongain Publishes Hydrophobic Interaction Chromatography Market Report 2021-2031

29 October 2020
Pharma

Visiongain has published a new report on Hydrophobic Interaction Chromatography Market Report : Forecasts by Product & Services (Resin, Columns (Empty, Prepacked), Buffer), Sample (Monoclonal Antibodies, Vaccines), End User (Pharmaceutical Companies, CROs & CMOs, Research Institutes). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Hydrophobic Interaction Chromatography market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031. Global Hydrophobic Interaction Chromatography (HIC) is one of the most extensively used methods for splitting and cleansing proteins in their native state. HIC also proves to be quite useful in isolating protein complexes and in studying protein folding and unfolding.

Various products in hydrophobic interaction chromatography market includes resins, buffers, and columns and increasingly being demanded for protein purification applications by pharmaceuticals companies, research institutes, and contract research organisation in various parts of the world. This will drive the market to the growth of this sector.

COVID-19 Impact on Global Hydrophobic Interaction Chromatography Market
In this period of pandemic COViD 19 this market is likely to grow in rapidgrowth rate due to the great demand of several antibodies for many diseases an especially for this pandemic COViD 19. Moreover this pandemic has no specific medicine for this disease so the demand for antibodies is increasing. Hence in this pandemic this market is growing with tremendous speed.

Market Drivers
The rise in demand for monoclonal antibodies in oncology is a key factor driving the demand for HIC separation technique. Rising research and development of monoclonal antibodies for finding efficacious therapies for various diseases is also boosting the market. The growing focus of pharma companies across the globe on therapeutic antibodies has imparted a big fillip to the demand for HIC. The hydrophobic interaction chromatography market is increasingly benefitting rising research and development funding by biopharmaceutical companies in developed regions.

Segment Analysis
In this report, the market has been categorized based on product & service, sample type, end user, and region. The HIC products market includes resins, columns, buffers, and other HIC products. HIC resins are expected to dominate the products market during the forecast period. This segment is also estimated to grow at the highest CAGR during the forecast period owing to the increasing demand for HIC resins for the purification of hydrophobic protein molecules.

On the grounds of sample type, the global hydrophobic interaction chromatography market is classified into monoclonal antibodies, vaccines, and other samples. In 2020, the monoclonal antibodies segment is expected to account for the largest share of the global hydrophobic interaction chromatography market. This large share of this segment is attributed to increasing application of mAbs in autoimmune disorders, CVD, infectious diseases, and cancer and also the current spread of COVID-19 globally.

Competitive Landscape
Some of the companies mentioned-GE Healthcare (US), Bio-Rad laboratories(US), Sartorius(Germany), Thermo Fisher Scientia(US) , Tosoh Corporation (Japan).

Hydrophobic interaction chromatography market is amalgamated in nature with a major share contributed by top companies in this market such as GE Healthcare, Tosoh Corporation, Merck, and Bio-Rad. Positions for this market have been derived on the basis of several features such as segmental revenue, organic and inorganic growth strategies, brand image, product portfolios, product innovation, and regional presence.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever